BSX vs LOAR · P/E 20, rev $10.65B vs P/E 96, rev $496.3M
Boston Scientific Corp (BSX) versus Loar Holdings Inc. (LOAR) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Loar Holdings Inc. (LOAR) is a aerospace & defense company listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LOAR revenue for 2025-12-31 was $496.3M. Net income was $72.1M. Revenue was up 23.2% from 2024-12-31 to 2025-12-31. LOAR currently screens at market cap $6.36B and trailing P/E 95.7.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LOAR currently screens at market cap $6.36B and trailing P/E 95.7.
Not investment advice. Open the BSX and LOAR stock pages for the full models.
Not investment advice.